Literature DB >> 6432149

Screening cord blood for sickle haemoglobinopathies in Brent.

J Henthorn, E Anionwu, M Brozovic.   

Abstract

Between 1981 and 1983, 3165 consecutive specimens of cord blood were tested at the Central Middlesex Hospital for the presence of an abnormal haemoglobin: the incidence of sickle cell trait was 2.8%, of HbC trait 0.9%, and the overall incidence of an abnormal haemoglobin at birth was 6.9%. Five babies with homozygous sickle cell disease, three with HbSC, and three with either HbCC or HbC beta thalassaemia were detected. Twenty two per cent of the mothers were of Afro-Caribbean origin. The cost of the test was 30p. An H6000 blood count was carried out on 1000 consecutive cord blood samples. The mean red cell volume was 97.95 (SD 3.67) fl. Thirteen cord blood samples had a mean cell volume below 85 fl, and all contained Hb Barts. In addition, six samples with a mean cell volume between 86 and 92 fl also showed Hb Barts on electrophoresis. The overall incidence of Hb Barts was 2.1%. These results indicate that the incidence of HbSS and HbSC on neonatal screening in Brent is similar to that found in the urban areas of North America and that the number may be predicted from the number of births to mothers of Afro-Caribbean origin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432149      PMCID: PMC1442533          DOI: 10.1136/bmj.289.6443.479

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Neonatal screening for haemoglobinopathy. Results in 7691 Manchester newborns.

Authors:  D I Evans; V M Blair
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

2.  Natural history of sickle cell disease--the first ten years.

Authors:  D R Powars
Journal:  Semin Hematol       Date:  1975-07       Impact factor: 3.851

3.  Screening cord bloods for detection of sickle cell disease in Jamaica.

Authors:  B E Serjeant; M Forbes; L L Williams; G R Serjeant
Journal:  Clin Chem       Date:  1974-06       Impact factor: 8.327

4.  Little shocks.

Authors:  W R Lee
Journal:  Practitioner       Date:  1981-11

5.  Early deaths in Jamaican children with sickle cell disease.

Authors:  D W Rogers; J M Clarke; L Cupidore; A M Ramlal; B R Sparke; G R Serjeant
Journal:  Br Med J       Date:  1978-06-10

6.  Current sickle cell screening program for newborns in New York City, 1979-1980.

Authors:  R Grover; S Shahidi; B Fisher; D Goldberg; D Wethers
Journal:  Am J Public Health       Date:  1983-03       Impact factor: 9.308

7.  Newborn screening for sickling hemoglobinopathies. Houston, 1976 to 1980.

Authors:  R L Nussbaum; C Powell; H L Graham; C T Caskey; D J Fernbach
Journal:  Am J Dis Child       Date:  1984-01

8.  Neonatal screening for sickle haemoglobinopathies in Birmingham.

Authors:  K D Griffiths; D N Raine; J R Mann
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27
  8 in total
  6 in total

1.  Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study.

Authors:  M E Horn; M C Dick; B Frost; L R Davis; A J Bellingham; C E Stroud; J W Studd
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-15

2.  Evaluation of eight and a half years of neonatal screening for haemoglobinopathies in Birmingham.

Authors:  P D Griffiths; J R Mann; P J Darbyshire; A Green
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-04

Review 3.  Management of sickle cell disease.

Authors:  M Brozović; S Davies
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

4.  Acute admissions of patients with sickle cell disease who live in Britain.

Authors:  M Brozović; S C Davies; A I Brownell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-09

5.  Prediction and diagnosis of sickling disorders in neonates.

Authors:  N Adjaye; B J Bain; P Steer
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

6.  Sickle cell disease in Britain.

Authors:  M Brozović; E Anionwu
Journal:  J Clin Pathol       Date:  1984-12       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.